Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weidong Han

Showing results (361-370 of 392) with videos related to

Pageof 40
Sort By:
Oncotarget|September 13, 2015
p53 controls colorectal cancer cell invasion by inhibiting the NF-κB-mediated activation of FascinXinbing Sui, Jing Zhu, Haimei Tang, et al.
Oncotarget|September 30, 2016
The efficacy and safety of anti-PD-1/PD-L1 antibodies for treatment of advanced or refractory cancers: a meta-analysisTengfei Zhang, Jing Xie, Seiji Arai, et al.
Nature Communications|April 15, 2026
Demethylation-primed tandem CD19/CD20 CAR T cells in relapsed/refractory B-cell lymphoma: a phase I/II trialChunmeng Wang, Yelei Guo, Fuxin Han, et al.
Journal of Immunology Research|June 26, 2014
Low-dose decitabine-based chemoimmunotherapy for patients with refractory advanced solid tumors: a phase I/II reportHui Fan, Xuechun Lu, Xiaohui Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2019
Addition of Low-Dose Decitabine to Anti-PD-1 Antibody Camrelizumab in Relapsed/Refractory Classical Hodgkin LymphomaJing Nie, Chunmeng Wang, Yang Liu, et al.
Cell Research|August 26, 2020
Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapyMengze Lv, Meixia Chen, Rui Zhang, et al.
Cell Reports. Medicine|December 31, 2025
Discovery, delineation, and therapeutic targeting of a hyper-translation pathway driving cytokine release syndromeXingxian Liu, Jiaqi Li, Yajing Zhang, et al.
Oncoimmunology|October 10, 2015
Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemiaHanren Dai, Wenying Zhang, Xiaolei Li, et al.
Scientific Reports|April 16, 2014
JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagyXinbing Sui, Na Kong, Xian Wang, et al.
Journal of Medicinal Chemistry|August 19, 2024
Rational Design of a Novel 6<i>H</i>-Benzo[<i>c</i>]chromen Series as Selective PI3Kα InhibitorsXue Shi, Heng Feng, Haigang Tian, et al.
Pageof 40

Showing results (361-370 of 392) with videos related to

Sort By:
Pageof 40
Oncotarget|September 13, 2015
p53 controls colorectal cancer cell invasion by inhibiting the NF-κB-mediated activation of FascinXinbing Sui, Jing Zhu, Haimei Tang, et al.
Oncotarget|September 30, 2016
The efficacy and safety of anti-PD-1/PD-L1 antibodies for treatment of advanced or refractory cancers: a meta-analysisTengfei Zhang, Jing Xie, Seiji Arai, et al.
Nature Communications|April 15, 2026
Demethylation-primed tandem CD19/CD20 CAR T cells in relapsed/refractory B-cell lymphoma: a phase I/II trialChunmeng Wang, Yelei Guo, Fuxin Han, et al.
Journal of Immunology Research|June 26, 2014
Low-dose decitabine-based chemoimmunotherapy for patients with refractory advanced solid tumors: a phase I/II reportHui Fan, Xuechun Lu, Xiaohui Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2019
Addition of Low-Dose Decitabine to Anti-PD-1 Antibody Camrelizumab in Relapsed/Refractory Classical Hodgkin LymphomaJing Nie, Chunmeng Wang, Yang Liu, et al.
Cell Research|August 26, 2020
Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapyMengze Lv, Meixia Chen, Rui Zhang, et al.
Cell Reports. Medicine|December 31, 2025
Discovery, delineation, and therapeutic targeting of a hyper-translation pathway driving cytokine release syndromeXingxian Liu, Jiaqi Li, Yajing Zhang, et al.
Oncoimmunology|October 10, 2015
Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemiaHanren Dai, Wenying Zhang, Xiaolei Li, et al.
Scientific Reports|April 16, 2014
JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagyXinbing Sui, Na Kong, Xian Wang, et al.
Journal of Medicinal Chemistry|August 19, 2024
Rational Design of a Novel 6<i>H</i>-Benzo[<i>c</i>]chromen Series as Selective PI3Kα InhibitorsXue Shi, Heng Feng, Haigang Tian, et al.
Pageof 40